Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma

Authors: Tomoaki Yoh, MD, PhD, Satoru Seo, MD, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

In the era of multidisciplinary surgical strategies for the treatment of hepatocellular carcinoma (HCC), preoperative assessment of prognosis plays an increasingly pivotal role. However, existing prognostic systems were not developed using only objective variables available preoperatively, and therefore do not provide ideal prognostication for patients undergoing hepatectomy for HCC. The albumin–bilirubin (ALBI) grade was recently established as an objective parameter that estimates liver function.1 However, as a candidate marker that can be incorporated with the ALBI grade in a preoperative prognostic model, we focused on 18F-fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) imaging, which visualizes tumor glucose metabolism.2,3 The purpose of our study was to develop a preoperative prognostic model using clinical parameters involving 18F-FDG-PET imaging findings and the ALBI grade for patients undergoing hepatectomy for solitary HCC.4
Literature
1.
go back to reference Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade. J Clin Oncol. 2015;33:550–58.CrossRefPubMed Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade. J Clin Oncol. 2015;33:550–58.CrossRefPubMed
2.
go back to reference Seo S, Hatano E, Higashi T, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res. 2007;13:427–33.CrossRefPubMed Seo S, Hatano E, Higashi T, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res. 2007;13:427–33.CrossRefPubMed
3.
go back to reference Kitamura K, Hatano E, Higashi T, et al. Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J Hepatol. 2011;55:846–57.CrossRefPubMed Kitamura K, Hatano E, Higashi T, et al. Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J Hepatol. 2011;55:846–57.CrossRefPubMed
4.
go back to reference Yoh T, Seo S, Ogiso S, et al. Proposal of a new preoperative prognostic model for solitary hepatocellular carcinoma incorporating 18F-FDG-PET imaging with the ALBI grade. Ann Surg Oncol. 2018; 25:542–9.CrossRefPubMed Yoh T, Seo S, Ogiso S, et al. Proposal of a new preoperative prognostic model for solitary hepatocellular carcinoma incorporating 18F-FDG-PET imaging with the ALBI grade. Ann Surg Oncol. 2018; 25:542–9.CrossRefPubMed
5.
go back to reference Zhou WP, Lai EC, Li AJ, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg. 2009;249:195–202.CrossRefPubMed Zhou WP, Lai EC, Li AJ, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg. 2009;249:195–202.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma
Authors
Tomoaki Yoh, MD, PhD
Satoru Seo, MD, PhD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6796-8

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue